Join
Live feed
·
PRReleasevia Quantisnow
Elicio Therapeutics Inc. logo

Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer

ByQuantisnow·Wall Street's wire, on your screen.
ELTX· Elicio Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELTX (Elicio Therapeutics Inc.) and more on Quantisnow.